Etiévant C - Search Results

1

Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents.

Barret JM, Kruczynski A, Etiévant C, Hill BT. Barret JM, et al. Among authors: etievant c. Cancer Chemother Pharmacol. 2002 Jun;49(6):479-86. doi: 10.1007/s00280-002-0451-5. Epub 2002 Apr 6. Cancer Chemother Pharmacol. 2002. PMID: 12107553

2

The combination of the tetrazolium derivative reduction (MTT) and digital cell image analysis to monitor in vitro the cytotoxicity of anti-neoplastic drugs.

Etievant C, Kruczynski A, Pauwels O, Kiss R. Etievant C, et al. Anticancer Res. 1991 Jan-Feb;11(1):305-11. Anticancer Res. 1991. PMID: 2018364

3

Monitoring of morphonuclear characteristics of hormone-sensitive and insensitive HCT-15 and LOVO human colorectal cells by means of digital cell image analysis.

Darro F, Kruczynski A, Etievant C, Martinez J, Kiss R. Darro F, et al. Among authors: etievant c. Anticancer Res. 1993 Mar-Apr;13(2):515-22. Anticancer Res. 1993. PMID: 7685991

4

Characterization of the differentiation of human colorectal cancer cell lines by means of Voronoi diagrams.

Darro F, Kruczynski A, Etievant C, Martinez J, Pasteels JL, Kiss R. Darro F, et al. Among authors: etievant c. Cytometry. 1993 Oct;14(7):783-92. doi: 10.1002/cyto.990140711. Cytometry. 1993. PMID: 8243207 Free article.

5

Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.

Kruczynski A, Barret JM, Etiévant C, Colpaert F, Fahy J, Hill BT. Kruczynski A, et al. Among authors: etievant c. Biochem Pharmacol. 1998 Mar 1;55(5):635-48. doi: 10.1016/s0006-2952(97)00505-4. Biochem Pharmacol. 1998. PMID: 9515574

6

Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series.

Etievant C, Schambel P, Guminski Y, Barret JM, Imbert T, Hill BT. Etievant C, et al. Anticancer Drug Des. 1998 Jun;13(4):317-36. Anticancer Drug Des. 1998. PMID: 9627671

7

Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.

Etievant C, Barret JM, Kruczynski A, Perrin D, Hill BT. Etievant C, et al. Invest New Drugs. 1998;16(1):3-17. doi: 10.1023/a:1006022811895. Invest New Drugs. 1998. PMID: 9740539

8

Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611.

Daley L, Guminski Y, Demerseman P, Kruczynski A, Etiévant C, Imbert T, Hill BT, Monneret C. Daley L, et al. Among authors: etievant c. J Med Chem. 1998 Nov 5;41(23):4475-85. doi: 10.1021/jm9800752. J Med Chem. 1998. PMID: 9804687

9

Novel artificial endonucleases inhibit base excision repair and potentiate the cytotoxicity of DNA-damaging agents on L1210 cells.

Barret JM, Etiévant C, Fahy J, Lhomme J, Hill BT. Barret JM, et al. Among authors: etievant c. Anticancer Drugs. 1999 Jan;10(1):55-65. doi: 10.1097/00001813-199901000-00008. Anticancer Drugs. 1999. PMID: 10194548

10

F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.

Perrin D, van Hille B, Barret JM, Kruczynski A, Etiévant C, Imbert T, Hill BT. Perrin D, et al. Among authors: etievant c. Biochem Pharmacol. 2000 Apr 1;59(7):807-19. doi: 10.1016/s0006-2952(99)00382-2. Biochem Pharmacol. 2000. PMID: 10718339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters